NO20080065L - Farmasoytiske preparater av ikke-mikronisert (4-klorfenyl)[4-(4-pyridylmetyl)ftalazin-1-yl] og salter derav, med umiddelbar frigivelse og hoyt legemiddelinnhold - Google Patents

Farmasoytiske preparater av ikke-mikronisert (4-klorfenyl)[4-(4-pyridylmetyl)ftalazin-1-yl] og salter derav, med umiddelbar frigivelse og hoyt legemiddelinnhold

Info

Publication number
NO20080065L
NO20080065L NO20080065A NO20080065A NO20080065L NO 20080065 L NO20080065 L NO 20080065L NO 20080065 A NO20080065 A NO 20080065A NO 20080065 A NO20080065 A NO 20080065A NO 20080065 L NO20080065 L NO 20080065L
Authority
NO
Norway
Prior art keywords
phthalazin
pyridylmethyl
micronized
chlorophenyl
immediate release
Prior art date
Application number
NO20080065A
Other languages
English (en)
Norwegian (no)
Inventor
Thomas Backensfeld
Torsten Wagner
Adrian Funke
Kai Juergens
Kai Thode
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20080065L publication Critical patent/NO20080065L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20080065A 2005-06-07 2008-01-04 Farmasoytiske preparater av ikke-mikronisert (4-klorfenyl)[4-(4-pyridylmetyl)ftalazin-1-yl] og salter derav, med umiddelbar frigivelse og hoyt legemiddelinnhold NO20080065L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05090166A EP1731153A1 (en) 2005-06-07 2005-06-07 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)¬4-(4-pyridylmethyl)phthalazin-1-yl| and salts thereof
PCT/EP2006/005600 WO2006131393A1 (en) 2005-06-07 2006-06-06 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof

Publications (1)

Publication Number Publication Date
NO20080065L true NO20080065L (no) 2008-03-06

Family

ID=34938467

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080065A NO20080065L (no) 2005-06-07 2008-01-04 Farmasoytiske preparater av ikke-mikronisert (4-klorfenyl)[4-(4-pyridylmetyl)ftalazin-1-yl] og salter derav, med umiddelbar frigivelse og hoyt legemiddelinnhold

Country Status (21)

Country Link
EP (2) EP1731153A1 (es)
JP (1) JP2008542420A (es)
KR (1) KR20080031005A (es)
CN (1) CN101242840A (es)
AR (1) AR053889A1 (es)
AU (1) AU2006256852A1 (es)
BR (1) BRPI0613393A2 (es)
CA (1) CA2610975A1 (es)
CR (1) CR9563A (es)
DO (1) DOP2006000127A (es)
EC (1) ECSP078038A (es)
GT (1) GT200600242A (es)
IL (1) IL187905A0 (es)
MX (1) MX2007015494A (es)
NO (1) NO20080065L (es)
PE (1) PE20070319A1 (es)
RU (1) RU2007147951A (es)
TW (1) TW200716115A (es)
UY (1) UY29582A1 (es)
WO (1) WO2006131393A1 (es)
ZA (1) ZA200800112B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958616A1 (en) * 2007-02-13 2008-08-20 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical formulations of 1-[4-chloroanilino]-4-[4-pyridylmethyl] phthalazine or salts thereof
AR101476A1 (es) 2014-08-07 2016-12-21 Acerta Pharma Bv Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion

Also Published As

Publication number Publication date
IL187905A0 (en) 2008-03-20
DOP2006000127A (es) 2006-12-15
AU2006256852A8 (en) 2006-12-14
CR9563A (es) 2008-02-20
RU2007147951A (ru) 2009-07-20
JP2008542420A (ja) 2008-11-27
BRPI0613393A2 (pt) 2011-01-11
EP1731153A1 (en) 2006-12-13
EP1888072A1 (en) 2008-02-20
GT200600242A (es) 2007-02-09
ZA200800112B (en) 2010-06-30
UY29582A1 (es) 2007-01-31
AR053889A1 (es) 2007-05-23
PE20070319A1 (es) 2007-04-12
CN101242840A (zh) 2008-08-13
AU2006256852A1 (en) 2006-12-14
WO2006131393A1 (en) 2006-12-14
KR20080031005A (ko) 2008-04-07
CA2610975A1 (en) 2006-12-14
MX2007015494A (es) 2008-02-22
TW200716115A (en) 2007-05-01
ECSP078038A (es) 2008-01-23

Similar Documents

Publication Publication Date Title
NO20080164L (no) N-(pyridin-2-yl)-sulfonamidderivater
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
NO20065190L (no) Farmasoytiske sammensetninger omfattende en amfifil stivelse
WO2008107149A3 (de) Darreichungsform mit erschwertem missbrauch
UA92349C2 (ru) Полиморфы этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1-метил-1н-бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
NO20084935L (no) Nikotinbaerende vaksineformulering
MX2010003923A (es) Formulacion farmaceutica de valsartan.
WO2005018605A3 (en) Novel formulation of ropinirole
EA201170512A1 (ru) Композиция для перорального введения
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
NO20080066L (no) Farmasoytiske preparater av mikronisert (4-klorfenyl) [4-(4-pyridylmetyl)ftalazin-1-yl] og salter derav, med umiddelbar frigivelse og hoyt legemiddelinnhold
WO2007124700A3 (en) Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
WO2008013823A3 (en) Co-crystals of (2r-trans)-6-chloro-5-[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n,1-trimethyl-alpha-oxo-1h-indole-3-acetamide
NO20080065L (no) Farmasoytiske preparater av ikke-mikronisert (4-klorfenyl)[4-(4-pyridylmetyl)ftalazin-1-yl] og salter derav, med umiddelbar frigivelse og hoyt legemiddelinnhold
SG169381A1 (en) New citrate salt of an indole derivative and its pharmaceutical use
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
NO20073772L (no) Preparater som omfatter et epotilon, og fremstillingsfremgangsmate
NO20051463L (no) Inhaleringssammensetninger med hoy legemiddelandel
WO2008129851A1 (ja) 一酸化窒素合成酵素活性化剤
WO2005105081A3 (en) Therapeutic formulations of desoxyepothilones
NO20085423L (no) stabil formulering omfattende fuktighetsfolsomt legemiddel og fremgangsmate for fremstilling derav
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
NO20075508L (no) Stannsoporfinpreparater og administrering
WO2009001673A1 (ja) Ａｔｐ含有免疫アジュバント

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application